What are you looking for?
This episode of The Ophthalmic Project spotlights a novel, non-invasive glaucoma treatment developed by ViaLase using femtosecond laser technology. Host Mark Dlugoss and ViaLase CEO Shawn O’Neil discuss the origins of the technology, its evolution from early laser research, and the development of the FLIGHT procedure, an image-guided, high-precision trabeculotomy designed to lower intraocular pressure.... ...
Geographic disparities in glaucoma surgical care were identified in a nationwide analysis of hospital-based glaucoma diagnoses and procedures, highlighting potential challenges in...
Combining the sustained-release travoprost implant iDose TR with either iStent infinite implantation or canaloplasty significantly reduced intraocular pressure (IOP) and dependence on...
A novel miniaturized glaucoma drainage device, known as the eyeValve, demonstrated sustained intraocular pressure (IOP) control and a favorable safety profile in...
This episode of The Ophthalmic Project spotlights a novel, non-invasive glaucoma treatment developed by ViaLase using femtosecond laser technology. Host Mark Dlugoss and ViaLase CEO Shawn O’Neil discuss the origins... ...
Geographic disparities in glaucoma surgical care were identified in a nationwide analysis of hospital-based glaucoma diagnoses and procedures, highlighting potential challenges in ensuring equitable access to treatment as populations continue...
Combining the sustained-release travoprost implant iDose TR with either iStent infinite implantation or canaloplasty significantly reduced intraocular pressure (IOP) and dependence on topical IOP-lowering medications within 3 months, regardless of...
A novel miniaturized glaucoma drainage device, known as the eyeValve, demonstrated sustained intraocular pressure (IOP) control and a favorable safety profile in a first-in-human feasibility study involving 6 blind eyes...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual-incretin therapies may have both protective and adverse ocular effects, although current clinical evidence remains mixed, according to a recent review. The therapies, widely... ...
Implantation of the PreserFlo MicroShunt significantly reduced intraocular pressure (IOP) and medication use in children with refractory glaucoma, according to a study. Investigators, however, did report declining long-term success rates...
The use of iStent in glaucoma surgery has become more integrated into routine glaucoma care over the past decade, according to a study that found its use has expanded in...
A review of adverse events found relatively low complication rates associated with the Hydrus Microstent, iStent inject W, and iStent infinite glaucoma devices, according to a poster presented at the...